FDA Inspection
Winder Laboratories, LLCWinder Laboratories, LLC – FDA Inspection, Mar 13, 2020
Record Details
This FDA Inspection record concerns Winder Laboratories, LLC, with an inspection on March 13, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Winder Laboratories, LLC
- Inspection Date
- March 13, 2020
- Product Type
- Drugs
View Company Profile
ID · 3145fb1e-4a4a-4f4f-ba36-6cc53c806293
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120766
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.198(b)(3)Reason for Not Conducting Complaint Investigation
- 21 CFR 211.84(d)(6)Objectionable microbiological contamination
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Winder Laboratories, LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2025 | OAI | Atlanta District Office | Drug Quality Assurance |
| February 5, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 3, 2023 | VAI | Atlanta District Office | |
| July 18, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 9, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Winder Laboratories, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.